CONSOLIDATED AND COMBINED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands		3 Months Ended	9 Months Ended		12 Months Ended
		Mar. 19, 2019	Dec. 31, 2019		Dec. 31, 2021		Dec. 31, 2020
REVENUES
REVENUES		$ 118,452	$ 443,781		$ 144,031		$ 120,925
COST OF REVENUES AND OPERATING EXPENSES
Administrative		2,498	13,986		15,526		18,957
Salary, benefits and payroll taxes		29,349	32,300		28,151		20,138
Amortization of intangible assets		755	13,174		16,829		16,823
Goodwill and tradename intangible assets impairment							190,777
Total cost of revenues and operating expenses		133,395	442,657		196,091		385,929
(Loss) income from operations		(14,943)	1,124		(52,060)		(265,004)
OTHER (EXPENSE) INCOME, NET
Interest expense and warrant issuance costs		(6,316)	(13,522)		(13,488)		(16,089)
Loss on extinguishment of debt		(3,413)
Interest and other income			43		55		30
Change in fair value of warrant liabilities			(19,700)		(2,600)		(6,100)
Total other expense, net		(9,729)	(33,179)		(16,033)		(22,159)
Loss before income tax expense (benefit)		(24,672)	(32,055)		(68,093)		(287,163)
INCOME TAX EXPENSE (BENEFIT)		109	(120)		429		814
NET LOSS		(24,781)	(31,935)		(68,522)		(287,977)
Net income attributable to noncontrolling interest		678	3,334
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS AND PARENT, RESPECTIVELY		(25,459)	$ (35,269)	[1]	$ (68,522)	[1]	$ (287,977)	[1]
NET LOSS PER VOTING AND NON-VOTING SHARE
Basic and diluted			$ (0.58)		$ (0.76)		$ (3.87)
WEIGHTED-AVERAGE SHARES OUTSTANDING
Basic and diluted	[2]		61,118		90,134		74,359
Service [Member]
REVENUES
REVENUES		91,280	$ 339,793		$ 115,945		$ 93,682
COST OF REVENUES AND OPERATING EXPENSES
Cost of Revenue		76,836	292,844		108,939		107,258
Product [Member]
REVENUES
REVENUES		27,172	103,988		28,086		27,243
COST OF REVENUES AND OPERATING EXPENSES
Cost of Revenue		$ 23,957	$ 90,353		$ 26,646		$ 31,976

[1] Calculated as total net loss less amounts attributable to noncontrolling interest.

[2] Potential common shares under the treasury stock method were antidilutive because the Company reported a net loss in this period and the effect of the change in the fair value of warrants was antidilutive. Consequently, the Company did not have any adjustments in this period between basic and diluted loss per share related to stock options, warrants, deferred shares and restricted stock.